The festive season is fast approaching which means the 43rd Annual J.P. Morgan Healthcare Conference is too! We'll be in San Francisco to connect with innovators just like you. 🤝 Our experts Jenny Gattari, CDMO Sales Lead North America and Kate Byrne, Custom Drug Product Sales, will be on hand to discover how our expertise can help you reach the patients waiting. Book a meeting with our team via PC1BD@pfizer.com #Pharma #Biotech #JPMorgan #JPM2025
Pfizer CentreOne
Pharmaceutical Manufacturing
New York, New York 30,428 followers
Discover how we are altogether different.
About us
As an award winning global CDMO, Pfizer CentreOne uses Pfizer’s extensive scientific and technical expertise to manufacture medicines for pharmaceutical and biotech companies like yours. We leverage cutting-edge development and commercial manufacturing solutions to offer contract development & manufacturing services from small to large scale for oral solids, sterile injectables, small molecules and biologics, cell and gene therapies; as well as regulatory services. Visit www.pfizercentreone.com for more information Disclaimer: External links found in posts on this page are neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of external sites.
- Website
-
https://www.pfizercentreone.com/
External link for Pfizer CentreOne
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- New York, New York
Updates
-
🗓️ 2024 has almost come to an end, and it has been a year marked by significant therapeutic advancements across biologics, oral solid dosage (OSD) forms, and sterile injectables. 💡 Our Pfizer experts have shared insights on many of these areas, from the benefits of working with an integrated CDMO partner — to overcoming supply chain challenges and navigating the complex sterile injectables landscape to streamlining your OSD’s path to market. Click the link below to access these expert resources on our Altogether Different Perspectives page 👇 https://lnkd.in/emPnsjFx #CDMO #DrugDevelopment #DrugManufacturing #Pharma
-
Every second counts for patients awaiting life-changing treatments for rare diseases because time is life. When our customer needed its cystic fibrosis treatment to accelerate towards clinical trials, we worked closely to rapidly deliver this treatment. As a result of our work together, the turnaround time from the engineering batch to the clinical batch was just five weeks, compared with a standard timeline of 8-12 weeks. Learn more about how our complementary cultures and close communication helped take this treatment to patients at a greater speed below 👇 https://lnkd.in/eMnmuGUe #GeneTherapy #CDMO #CGTs #CysticFibrosis
-
As your project advances along its journey to patients, protecting your intellectual property is a key priority. 🗝️ The stakes are high and the risks are real. That's why we've built a culture of confidentiality with robust systems and processes designed to safeguard your most valuable assets. From controlled access to information and strict confidentiality agreements to rigorous employee training and secure data management, we're committed to fostering an environment where you can confidently innovate. Ready to bring your pharmaceutical product to market with peace of mind? Learn more about how we protect your product in our brochure below 👇 https://lnkd.in/diZDrshW #IPProtection #CDMO #DrugManufacturing
-
The complexities of drug development and manufacturing can be challenging to navigate. From ensuring the quality of your product to securing regulatory approval and scaling your project as it grows, you face many potential hurdles to helping it reach the patients who need it most. As a leading global CDMO, powered by Pfizer, we have the expertise and capabilities to help. From oral solid dosage, to sterile injectables and biologics such as mAbs and ADCs, we offer tailored solutions to help meet your specific needs. Tell us your key challenges in selecting the right CDMO partner in our poll below! Discover how we can support your unique goals by downloading our guide here: https://lnkd.in/ejwgAqyg #DrugDevelopment #DrugManufacturing #CDMO
This content isn’t available here
Access this content and more in the LinkedIn app
-
Developing groundbreaking treatments for genetic diseases like cystic fibrosis is no easy feat. 🧬 The journey from concept to clinical trials is complex, from ensuring you have the right therapeutic expertise to navigating strict timelines and regulatory landscapes. When a pioneer in genetic medicines reached out to our Pfizer experts to help navigate these challenges, we were ready to help. Read the full case study to discover how a complementary culture and open communication helped advance their revolutionary cystic fibrosis treatment on its journey to patients. 👇 https://loom.ly/aNpyVSk #CycsticFibrosis #GeneTherapy #CDMO
-
Don't miss out on valuable insights from CPHI Milan! Thomas P Wilson, our Global Head of Business Development, shares his expertise in navigating the changing manufacturing landscape and building successful marketing strategies, at the ramarketing and Molecule to Market panel, hosted by Emma Banks. Watch the full video here: https://loom.ly/-V-P854 #CPHIMilan #Biopharma #MarketingStrategy
-
Happy #Thanksgiving to our U.S. colleagues, customers, and all those who celebrate! 🦃 We are so thankful for the hard work and incredible contributions of our team, and the support of our wonderful customers. However you choose to celebrate, we hope you have a wonderful holiday surrounded by loved ones!
-
Ready to unlock your antibody's full potential? 🔓 We're here to help unlock the biol-logic brilliance of your monoclonal antibody (mAb) therapeutic. 🧬 From our site in Sanford, North Carolina, we have: ⏳ 35+ years of expertise in adherent and suspension cell culture processes 💪 Industry-leading yield and productivity 🌍 A global network of support. Discover how to streamline your biologic on its journey to patients with the support of a leading CDMO, powered by Pfizer. 👇 https://lnkd.in/eSRxZ9dK #CDMO #MonoclonalAntibody #Therapeutic
-
Navigating the complexities of bringing your oral solid dose (OSD) product to market requires a strategic roadmap for success. From securing the specialized capabilities your product needs to scale production seamlessly, this journey presents challenges you must overcome. But what if you could make the complex simple? In our webinar, Pfizer's OSD experts detail how you can overcome these challenges with tips on: 🚧 Anticipating and mitigating risks throughout the development process 💡 Harnessing scalable infrastructure and specialized expertise ✅ Proven strategies for simplifying your path to market Watch on-demand below 👇 https://lnkd.in/eiu-SX_n #OralSolidDose #DrugManufacturing #CDMO